Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea.
The efficacy of currently recommended treatments is uncertain in patients with mild to moderate obstructive sleep apnea (apnea-hypopnea index [AHI], 5-30). A group of 114 sleep clinic patients with an AHI of 5-30 have participated in a randomized controlled crossover trial of 3 months of treatment with each of nasal continuous positive airway pressure (CPAP), a mandibular advancement splint, and a placebo tablet. Outcomes were sleep fragmentation and hypoxemia, daytime sleepiness, quality of life, neurobehavioral function, and blood pressure. Both active treatments improved sleep outcomes, but positive airway pressure had a greater effect. The quality of life, symptoms, and subjective but not objective sleepiness improved to a similar degree with both treatments; however, many of the improvements seen in neuropsychologic function and mood were not better than the placebo effect. Some aspects of nocturnal blood pressure were improved with the splint but not with CPAP. This study has shown that although both CPAP and mandibular advancement splint effectively treated sleep-disordered breathing and sleepiness, the expected response in neurobehavioral function was incomplete. This may be due to the splint having a lesser therapeutic effect and CPAP being poorly tolerated and therefore used less in this patient group.
Barnes
Maree
M
Institute for Breathing and Sleep, Austin Health, Melbourne, Victoria, Australia. maree.barnes@austin.org.au
McEvoy
R Douglas
RD
Banks
Siobhan
S
Tarquinio
Natalie
N
Murray
Christopher G
CG
Vowles
Norman
N
Pierce
Robert J
RJ
D045422:Continuous Positive Airway Pressure / Q000379:methods*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D019186:Mandibular Advancement / Q000295:instrumentation; D008875:Middle Aged; D009968:Orthodontic Appliances, Removable; D011788:Quality of Life; D020181:Sleep Apnea, Obstructive / Q000628:therapy*; D016896:Treatment Outcome